Stocks News

LAST PRICE
967.0000
TODAY'S CHANGE (%)
Trending Down-18.0200 (-1.8294%)

Bid / Lots
966.4800/ 4
Ask / Lots
968.3000/ 2
Open / Previous Close
974.8600 / 985.0200
Day Range
Low 964.2550
High 978.9300
52 Week Range
Low 684.8050
High 998.3250
Volume
168,570
below average

Search Criteria

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
Company	Country	Symbol

TD Direct Investing offers more research reports than any other discount brokerage in Canada. Provided from the industry's most trusted sources, our service includes timely, relevant information for the current trading day and comprehensive industry, sector, and insider trading reports for further analysis.

Open a New Account, or Login if you're a client.

Today
- INVESTIGATION ACTION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Regeneron Pharmaceuticals, Inc. and Encourages Investors with Losses to Contact the Firm, from 3 minutes ago by Dow Jones
  3 minutes ago by Dow Jones
  Companies Mentioned: REGN
  
  LOS ANGELES, CA / ACCESSWIRE / May 28, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Regeneron Pharmaceuticals, Inc. ("Regeneron" or "the Company") (NASDAQ:REGN) for violations of the securities laws.
- INVESTIGATION ACTION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Regeneron Pharmaceuticals, Inc. and Encourages Investors with Losses to Contact the Firm, from 3 minutes ago by Dow Jones
  3 minutes ago by Dow Jones
  Companies Mentioned: REGN
  
  LOS ANGELES, CA / ACCESSWIRE / May 28, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Regeneron Pharmaceuticals, Inc. ("Regeneron" or "the Company") (NASDAQ:REGN) for violations of the securities laws.
- Regeneron Pharmaceuticals, Inc. (REGN) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings, from 3 hours ago by Dow Jones
  3 hours ago by Dow Jones
  Companies Mentioned: REGN
  
  NEW YORK, NY / ACCESSWIRE / May 28, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Regeneron Pharmaceuticals, Inc. ("Regeneron" or "the Company") (NASDAQ:REGN). Investors who purchased Regeneron securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: https://bgandg.com/REGN/.
- IMPORTANT INVESTOR ALERT: The Schall Law Firm Announces it is Investigating Claims Against Regeneron Pharmaceuticals, Inc. and Encourages Investors with Losses to Contact the Firm, from 12 hours ago by Dow Jones
  12 hours ago by Dow Jones
  Companies Mentioned: REGN
  
  LOS ANGELES, CA / ACCESSWIRE / May 28, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Regeneron Pharmaceuticals, Inc. ("Regeneron" or "the Company") (NASDAQ:REGN) for violations of the securities laws.
Yesterday
- Regeneron Pharmaceuticals, Inc. (REGN) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings, from 11:01AM ET on Monday May 27, 2024 by Dow Jones
  11:01AM ET on Monday May 27, 2024 by Dow Jones
  Companies Mentioned: REGN
  
  NEW YORK, NY / ACCESSWIRE / May 27, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Regeneron Pharmaceuticals, Inc. ("Regeneron" or "the Company") (NASDAQ:REGN). Investors who purchased Regeneron securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: https://bgandg.com/REGN/.

Today
- Nvidia Rally Drives Nasdaq to Record, from 10 minutes ago by MT Newswires
  10 minutes ago by MT Newswires
  Companies Mentioned: VST, SPGI, MRVL, DG, NVDA, ANF, MRNA, BBY, BURL, COST, CRM, DKS
May 24, 2024
- Vertex Pharmaceuticals Insider Sold Shares Worth $3,168,704, According to a Recent SEC Filing, from 4:16PM ET on Friday May 24, 2024 by MT Newswires
  4:16PM ET on Friday May 24, 2024 by MT Newswires
  Companies Mentioned: VRTX
May 22, 2024
- Vertex Pharmaceuticals Insider Sold Shares Worth $6,795,294, According to a Recent SEC Filing, from 4:28PM ET on Wednesday May 22, 2024 by MT Newswires
  4:28PM ET on Wednesday May 22, 2024 by MT Newswires
  Companies Mentioned: VRTX
- US Equity Markets Close Down Wednesday After Fed Minutes Raise Inflation Concerns, from 4:06PM ET on Wednesday May 22, 2024 by MT Newswires
  4:06PM ET on Wednesday May 22, 2024 by MT Newswires
  Companies Mentioned: PDD, BIIB
- Vertex to Participate in Upcoming June Investor Conferences, from 4:05PM ET on Wednesday May 22, 2024 by Business Wire
  4:05PM ET on Wednesday May 22, 2024 by Business Wire
  Companies Mentioned: VRTX
- Sector Update: Health Care Stocks Slightly Higher Late Afternoon, from 4:02PM ET on Wednesday May 22, 2024 by MT Newswires
  4:02PM ET on Wednesday May 22, 2024 by MT Newswires
  Companies Mentioned: PFE, AVXL, BIIB, AMPH
- Sector Update: Health Care Stocks Advance Wednesday Afternoon, from 2:01PM ET on Wednesday May 22, 2024 by MT Newswires
  2:01PM ET on Wednesday May 22, 2024 by MT Newswires
  Companies Mentioned: BIIB, LFST, AMPH
- Sector Update: Health Care, from 1:35PM ET on Wednesday May 22, 2024 by MT Newswires
  1:35PM ET on Wednesday May 22, 2024 by MT Newswires
  Companies Mentioned: BIIB
- Biogen Agrees to Buy Human Immunology Biosciences For up to $1.8 Billion, from 12:42PM ET on Wednesday May 22, 2024 by MT Newswires
  12:42PM ET on Wednesday May 22, 2024 by MT Newswires
  Companies Mentioned: BIIB
- Top Midday Stories: US Targets August 1 Start Date for China Tariff Hikes; CFPB Says BNPL Requires Credit Card-Level Oversight; Target Shares Fall on Earnings Miss; Third BHP Bid Rejected by Anglo American, from 12:24PM ET on Wednesday May 22, 2024 by MT Newswires
  12:24PM ET on Wednesday May 22, 2024 by MT Newswires
  Companies Mentioned: JNJ, NVDA, TSLA, TGT, AMZN, DOCU, PDD, BHP, BIIB, GOOG

Regeneron Pharmaceuticals Inc
NASDAQ:REGNUnited States

Search Criteria

Today

INVESTIGATION ACTION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Regeneron Pharmaceuticals, Inc. and Encourages Investors with Losses to Contact the Firm, from 3 minutes ago by Dow Jones

INVESTIGATION ACTION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Regeneron Pharmaceuticals, Inc. and Encourages Investors with Losses to Contact the Firm, from 3 minutes ago by Dow Jones

Regeneron Pharmaceuticals, Inc. (REGN) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings, from 3 hours ago by Dow Jones

IMPORTANT INVESTOR ALERT: The Schall Law Firm Announces it is Investigating Claims Against Regeneron Pharmaceuticals, Inc. and Encourages Investors with Losses to Contact the Firm, from 12 hours ago by Dow Jones

Yesterday

Regeneron Pharmaceuticals, Inc. (REGN) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings, from 11:01AM ET on Monday May 27, 2024 by Dow Jones

Peers Headlines

Today

Nvidia Rally Drives Nasdaq to Record, from 10 minutes ago by MT Newswires

May 24, 2024

Vertex Pharmaceuticals Insider Sold Shares Worth $3,168,704, According to a Recent SEC Filing, from 4:16PM ET on Friday May 24, 2024 by MT Newswires

May 22, 2024

Vertex Pharmaceuticals Insider Sold Shares Worth $6,795,294, According to a Recent SEC Filing, from 4:28PM ET on Wednesday May 22, 2024 by MT Newswires

US Equity Markets Close Down Wednesday After Fed Minutes Raise Inflation Concerns, from 4:06PM ET on Wednesday May 22, 2024 by MT Newswires

Vertex to Participate in Upcoming June Investor Conferences, from 4:05PM ET on Wednesday May 22, 2024 by Business Wire

Sector Update: Health Care Stocks Slightly Higher Late Afternoon, from 4:02PM ET on Wednesday May 22, 2024 by MT Newswires

Sector Update: Health Care Stocks Advance Wednesday Afternoon, from 2:01PM ET on Wednesday May 22, 2024 by MT Newswires

Sector Update: Health Care, from 1:35PM ET on Wednesday May 22, 2024 by MT Newswires

Biogen Agrees to Buy Human Immunology Biosciences For up to $1.8 Billion, from 12:42PM ET on Wednesday May 22, 2024 by MT Newswires

Top Midday Stories: US Targets August 1 Start Date for China Tariff Hikes; CFPB Says BNPL Requires Credit Card-Level Oversight; Target Shares Fall on Earnings Miss; Third BHP Bid Rejected by Anglo American, from 12:24PM ET on Wednesday May 22, 2024 by MT Newswires